Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

7 Stocks That Could Skyrocket in the Next 12 Months

By Larry Ramer, InvestorPlace Contributor

With the macro environment becoming excellent and much of the Street starting to turn bullish, it's time to find superb stocks to buy. 

Bed Bath & Beyond Stock Alert: Sell Your BBBY Immediately!

By Larry Ramer, InvestorPlace Contributor

With Bed Bath & Beyond likely heading to bankruptcy sooner rather than later, investors should unload BBBY stock.

Dear META Stock Fans, Mark Your Calendars for TODAY

By Larry Ramer, InvestorPlace Contributor

META stock is in the news this morning because the company is reportedly undertaking its latest round of layoffs. 

NVDA Stock Alert: Is Nvidia Really Worth $355?

By Larry Ramer, InvestorPlace Contributor

NVDA stock is advancing in early trading. HSBC predicts that Nvidia will be boosted by high prices for its chips that enable AI systems.

Moderna (MRNA) Stock Sinks Despite Positive Cancer Vaccine Update

By Larry Ramer, InvestorPlace Contributor

MRNA stock is sinking this morning despite Moderna releasing positive Phase 2b data on its mRNA cancer vaccine yesterday.

3 Reasons TJX Stock Shines in Turbulent Times

By Larry Ramer, InvestorPlace Contributor

TJX stock is likely to rise as the company's stores continue to attract working-class and middle-class shoppers looking for bargains. 

7 Stocks to Sell in April Before They Crash and Burn

By Larry Ramer, InvestorPlace Contributor

Although the macro environment is turning quite favorable for equities, there are still many stocks to sell. 

3 Stocks to Buy That Could Be the Next Biotech Breakthrough

By Larry Ramer, InvestorPlace Contributor

Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.

The C3.ai Stock Debate: Overpriced or Underestimated?

By Larry Ramer, InvestorPlace Contributor

The valuation of AI stock was attractive many months ago, but at this point their price-sales ratio has become quite elevated.

3 Industries Set to Be Transformed by the AI Revolution

By Larry Ramer, InvestorPlace Contributor

AI will allow companies in many sectors to save a great deal of money and tremendously increase their revenue.

Load More